GetPortalImpactFactorByIdResp(projectId=1, id=676816449, cover=https://img.medsci.cn/images/journal/cover/2021/XXs_202109271314314570.jpg, fullname=Biomedicines, abbr=BIOMEDICINES, pyear=暂无数据, frequence=Q, articleNumbers=3690, citedSelf2015=null, acceptanceRate=null, submissionToAcceptance=null, averageReviewTime=平均1.2月, reviewFee=null, pageFee=2000.0, publishedRatio=2023年中国人文章占该期刊总数量暂无数据 (2022年为100.00%), issn=2227-9059, greenSci=https://www.greensci.net/search?kw=2227-9059, scijournal=https://www.scijournal.org/impact-factor-of-BIOMEDICINES.shtml, medsciHotlightString=null, medsciHotlightRealtime=10.904, medsciHotlight=12.118, medsciHotlight5year=5.63333, citescore=3.6, hIndex=28, impactFactor=4.7, orgnization=MDPI AG, orgnizationUrl=https://www.mdpi.com/journal/, country=Switzerland, countryCn=瑞典, isOa=1, isOaString=是, sciScie=null, bigclassCas=null, smallclassCas=工程技术 2 区, website=https://www.mdpi.com/journal/biomedicines, websiteHits=7723, guideForAuthor=https://www.mdpi.com/journal/biomedicines/instructions, guideForAuthorHits=2211, submitWebsite=https://susy.mdpi.com/user/manuscripts/upload?form[journal_id]=158, submitWebsiteHits=1500, content=<p style="color: #222222;"><em>Biomedicines</em> (ISSN 2227-9059) is an open access journal devoted to all aspects of research on human health and disease, the discovery and characterization of new therapeutic targets, therapeutic strategies, and research of naturally driven biomedicines, pharmaceuticals, and biopharmaceutical products. The topics include pathogenesis mechanisms of diseases, translational medical research, biomaterial in biomedical research, natural bioactive molecules, biologics, biosimilar, vaccines, gene therapies, cell-based therapies, targeted specific antibodies, recombinant therapeutic proteins, nanobiotechnology driven products, targeted therapy, bioimaging, biosensors, biomarkers, nanosimilars, and nano-biosimilars. The journal is open for the publication of studies conducted at the basic science, clinical development, and clinical trial stages. Furthermore, publications that address safety, pharmacovigilance regulatory, and ethical issues are welcome. We invite you to consider submitting your work to <em>Biomedicines</em>, be it original research or review articles, or toward developing Special Issues of current key topics.</p> <p style="color: #222222;">The aim of <em>Biomedicines</em> is to publish high-quality papers that address the challenges in bringing biological agents or novel targeted strategies through identification, development and, ultimately, to clinical use. Therefore, basic research, comprehensive preclinical studies, clinical development, and clinical trials are all within the scope of the journal.</p> <h2 style="color: rgba(20, 64, 153, 0.75);">Scope</h2> <ul style="color: #222222;"> <li>Pathogenesis and mechanisms of diseases</li> <li>Translational medical research</li> <li>Biomaterial in biomedical research</li> <li>Novel targets in various therapeutic areas: cardiovascular, vascular, hematology, oncology, neurology, orthopedics, dermatology, ophthalmology</li> <li>Biomarker discovery and early diagnosis research</li> <li>Drug discovery and drug development, biomedicine, and pharmacotherapy</li> <li>Natural biomedicine, including marine, plant, and animal-derived biomedicine</li> <li>Biopharmaceutical biomedicine: biologics and biosimilars</li> <li>Nanobiotechnological advances in biomedicine: nanomedicine, nanoscaffold implants (synthetic vascular graft), biosensors, bio-imaging, gene therapy, vaccine, cell therapy, and tissue engineering</li> <li>Pharmacovigilance, regulatory, and ethical issues</li> </ul>, totalCites=17347, brief=BIOMEDICINES杂志暂不明确行业，暂不明确子行业的级别不明杂志, articleType=本刊接收类型不明, medsciHeat=<span style="color: #0000ff;">蓝</span>, medsciComment=虽然从国际上看，影响力一般。另外，大家关注整体偏低了一些，但是这是中国本土SCI期刊，取得这样成绩也是相当不错的，希望大家多关注支持！, medsciExplanation=MedSci期刊指数是根据中国科研工作者（含医学临床，基础，生物，化学等学科）对SCI杂志的认知度，熟悉程度，以及投稿的量等众多指标综合评定而成。当然，具体的，您还可以结合“<a href='https://www.medsci.cn/sci/submit.do?id=676816449'>投稿经验系统</a>”，进行综合判断，这更是大家的实战经验，值得分享和参考。<br> 注意，上述MedSci期刊指数采用MedSci专利技术，由计算机系统自动计算，并给出建议，存在不准确的可能，仅供您投稿选择杂志时参考。, tags=[ImpactFactorTagDto(id=472748, tagName=骨科非肿瘤, createdHits=2), ImpactFactorTagDto(id=112, tagName=药学, createdHits=1), ImpactFactorTagDto(id=2341, tagName=miRNAs, createdHits=1), ImpactFactorTagDto(id=803, tagName=Cancer, createdHits=1), ImpactFactorTagDto(id=41385, tagName=bioinformatics, createdHits=1), ImpactFactorTagDto(id=44, tagName=医学, createdHits=1), ImpactFactorTagDto(id=119, tagName=肿瘤, createdHits=1), ImpactFactorTagDto(id=4027, tagName=生物学, createdHits=1), ImpactFactorTagDto(id=684, tagName=脑, createdHits=1)], citeScoreList=[GetImpactFactorCiteScoreListResponse(year=2020, citescore=3.6)], medsciIndexList=[GetImpactFactorMedsciIndexListResponse(year=2020, medsciHotlight=4.428), GetImpactFactorMedsciIndexListResponse(year=2021, medsciHotlight=12.472), GetImpactFactorMedsciIndexListResponse(year=2022, medsciHotlight=13.078), GetImpactFactorMedsciIndexListResponse(year=2023, medsciHotlight=13.925), GetImpactFactorMedsciIndexListResponse(year=2024, medsciHotlight=10.904)], citeScoreGradeList=[], totalJcrAreaList=[], pmcUrl=https://www.ncbi.nlm.nih.gov/nlmcatalog?term=2227-9059[ISSN], pubmedUrl=https://www.ncbi.nlm.nih.gov/pubmed?cmd=search&term=Biomedicines[ta], article_number=3295, article_number_cn=135, earlyWarning=中科院风险预警-低（2021）, linkOutUrl=null, isJournalMember=false, unscrambleContent=null, dayViewCount=false, endexampletyle=暂无数据)